Generative AI is expected to revolutionize drug discovery by designing new drugs independently. AI has already shown promise by generating novel designs for molecules with strong drug potential. This trend aligns with predictions that AI will have a significant role in generating new medications, as demonstrated by Google's DeepMind AI with the development of the protein AlphaFold. Using generative AI in drug discovery offers advantages such as the ability to produce a larger number of designs and think creatively beyond human limitations. It also allows for simulating traditional biological behavior and predicting drug interactions. AI-generated drugs have the potential to transform medicine and accelerate the drug development process. However, human clinical trials are still necessary to validate their effectiveness and safety.